Birthdays have always been a big deal for Ellory. But her 11th birthday took the cake. It was the first time in three years that ellory got to celebrate her birthday outside the hospital. More significantly, she commemorated another year of life - no small feat for young cancer survivor who undewent 850 days of chemotherapy as part of her treatment at Children's Hospital Colorado.
Children’s Colorado researchers are working every day to find less invasive, more effective pediatric cancer treatments. And that could mean a future where cancer is successfully treated without chemotherapy.
For example, Dr. Lia Gore, Chief of the Center for Cancer and Blood Disorders at Children’s Colorado, recently led a globe-spanning team of 20 hospitals to develop a new pediatric leukemia drug. Called blinatumomab, the drug targets acute lymphoblastic leukemia – the most common form of childhood cancer and the kind that Ellory fought...and won. The results have been impressive: widespread remissions and very few of the typical side effects of chemotherapy.
The drug is the first new treatment option for childhood leukemia to be approved by the FDA in more than a decade. And it never would have happened without the support of donors, who provided critical funding to support Dr. Gore’s research and collaboration efforts.
Children's Colorado is honored to partner with Mission of Hope as we work together to raise support for cancer research.